Heartland Advisors Inc. Decreases Holdings in Leidos Holdings, Inc. (NYSE:LDOS)

Heartland Advisors Inc. lessened its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS - Free Report) by 17.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 93,879 shares of the aerospace company's stock after selling 19,584 shares during the quarter. Heartland Advisors Inc. owned approximately 0.07% of Leidos worth $13,524,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in LDOS. Duncker Streett & Co. Inc. purchased a new stake in Leidos in the fourth quarter worth $27,000. Berbice Capital Management LLC bought a new position in Leidos in the fourth quarter worth $29,000. Mather Group LLC. grew its position in shares of Leidos by 143.1% in the 4th quarter. Mather Group LLC. now owns 265 shares of the aerospace company's stock worth $38,000 after buying an additional 156 shares during the period. Human Investing LLC purchased a new position in Leidos during the 4th quarter valued at about $52,000. Finally, Vision Financial Markets LLC bought a new stake in Leidos during the fourth quarter worth about $57,000. Institutional investors own 76.12% of the company's stock.

Insider Transactions at Leidos

In other news, Director Gary Stephen May sold 2,128 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total value of $279,278.72. Following the completion of the sale, the director now owns 11,264 shares in the company, valued at approximately $1,478,287.36. This trade represents a 15.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $134.56, for a total transaction of $203,320.16. Following the sale, the director now directly owns 6,408 shares of the company's stock, valued at $862,260.48. This represents a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company's stock.

Remove Ads

Leidos Price Performance

NYSE LDOS traded up $0.26 on Tuesday, reaching $135.20. The company had a trading volume of 331,459 shares, compared to its average volume of 1,143,816. The stock has a market capitalization of $17.33 billion, a PE ratio of 14.64, a price-to-earnings-growth ratio of 1.65 and a beta of 0.72. Leidos Holdings, Inc. has a 12 month low of $123.23 and a 12 month high of $202.90. The company has a quick ratio of 1.13, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The firm's 50 day moving average price is $137.11 and its 200 day moving average price is $153.52.

Leidos (NYSE:LDOS - Get Free Report) last posted its earnings results on Tuesday, February 11th. The aerospace company reported $2.37 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.13. Leidos had a return on equity of 30.93% and a net margin of 7.53%. As a group, equities analysts predict that Leidos Holdings, Inc. will post 10.62 earnings per share for the current year.

Leidos Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Friday, March 14th were paid a $0.40 dividend. The ex-dividend date was Friday, March 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.18%. Leidos's payout ratio is currently 17.32%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on LDOS shares. Cantor Fitzgerald raised Leidos to a "strong-buy" rating in a research report on Tuesday, February 25th. Truist Financial reduced their price target on shares of Leidos from $185.00 to $165.00 and set a "buy" rating for the company in a research report on Wednesday, February 12th. TD Cowen cut Leidos from a "buy" rating to a "hold" rating and lowered their price objective for the company from $200.00 to $165.00 in a research report on Wednesday, January 8th. UBS Group reduced their target price on Leidos from $162.00 to $156.00 and set a "neutral" rating for the company in a report on Wednesday, February 12th. Finally, Wells Fargo & Company lowered their price target on Leidos from $197.00 to $191.00 and set an "overweight" rating on the stock in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $178.07.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.